HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval
June 18, 2025

(NPR) – A drug with the potential to drastically curb the HIV epidemic just cleared its first regulatory hurdle.
On Wednesday, the Food and Drug Administration approved lenacapavir for the prevention of HIV. Clinical trial data from last year suggest just two injections a year provide near-complete protection against an HIV infection. (Read More)